Courtney D. DiNardo

Courtney D. DiNardo is a Professor in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center. Her research focuses on prognostication and personalized therapeutics for myeloid malignancies, including acute myeloid leukemia (AML). She holds a Master’s of Science in Clinical Epidemiology (2012) and has expertise in analyzing IDH mutations, 2HG levels, and patient outcomes in AML. Dr. DiNardo leads clinical trials for IDH1/IDH2-targeted therapies and venetoclax combinations in elderly AML patients. She co-founded MD Anderson’s Hereditary Hematologic Malignancy Clinic, addressing hereditary cancer syndromes in leukemia patients.

Her work integrates translational research with clinical practice, emphasizing combination therapies and precision medicine. Despite numerous clinical trial contributions, specific awards/grants are not detailed here. Advising and team collaborations remain unlisted in the provided text.